B7‐H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Cancer

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.27566PMID 22473715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B7‐H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis‐associated genes

  2012cited by this paper
• B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation

  2011cited by this paper
• Nuclear S100A4 is a novel prognostic marker in colorectal cancer.

  2010influential reference
• Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Nuclear trafficking of the epidermal growth factor receptor family membrane proteins

  2010cited by this paper
• Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

  2010cited by this paper
• Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule

  2010cited by this paper
• High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients

  2010cited by this paper
• B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis

  2010cited by this paper
• Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer

  2010cited by this paper
• Revised TN categorization for colon cancer based on national survival outcomes data.

  2010cited by this paper
• T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

  2009cited by this paper
• B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction

  2009cited by this paper
• Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer

  2009cited by this paper
• Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

  2009cited by this paper
• Trafficking of receptor tyrosine kinases to the nucleus.

  2009cited by this paper
• Clinical importance of B7-H3 expression in human pancreatic cancer

  2009cited by this paper
• Importins and Beyond: Non‐Conventional Nuclear Transport Mechanisms

  2009cited by this paper
• B7-H3 contributes to the development of pathogenic Th2 cells in a murine model of asthma

  2008cited by this paper
• Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell Carcinoma

  2008cited by this paper
• T-Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathologic Correlations and Association with Survival

  2008cited by this paper
• Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients

  2008cited by this paper
• B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.

  2008cited by this paper
• Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

  2008cited by this paper
• The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.

  2008cited by this paper
• Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy.

  2007cited by this paper
• Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

  2007cited by this paper
• B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.

  2007cited by this paper
• Integral and Associated Lysosomal Membrane Proteins

  2007cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis.

  2006cited by this paper
• Staging of colon and rectal cancer: from endoscopy to molecular markers

  2006cited by this paper
• Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.

  2005cited by this paper
• Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

  2005cited by this paper
• Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis

  2005cited by this paper
• © 2005 BioMed Central Ltd Summary

  2005cited by this paper
• B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+ Cytolytic T Cells1

  2004cited by this paper
• Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.

  2004cited by this paper
• Nuclear transport and cancer: from mechanism to intervention

  2004cited by this paper
• Different Genetic Features Associated with Colon and Rectal Carcinogenesis

  2004cited by this paper
• Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.

  2004cited by this paper
• Surveillance Strategies after Curative Treatment of Colorectal Cancer

  2004cited by this paper
• Nuclear localization of the metastasis‐related protein S100A4 correlates with tumour stage in colorectal cancer

  2003cited by this paper
• The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses

  2003cited by this paper
• Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.

  2002cited by this paper
• Nuclear lamins: building blocks of nuclear architecture.

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.

  2001cited by this paper
• B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

  2001cited by this paper
• Mechanisms of oncogenesis in colon versus rectal cancer

  2001cited by this paper
• Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells

  1998cited by this paper

• CD276 immature glycosylation drives colorectal cancer aggressiveness and T cell mediated immune escape

  2026cites this paper
• Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value

  2026cites this paper
• Palmitic acid-triggered B7H3 palmitoylation promotes immune escape

  2026cites this paper
• B7-H3 in Colorectal Adenocarcinoma: Are We Focusing on the Right Target?

  2025cites this paper
• B7-H3/CD276: Novel Immune Checkpoint and Jack of All Trades

  2025cites this paper
• A fc-engineered NKG2D × B7-H3 bispecific antibody enhances the antitumor activity by orchestrating cytotoxic lymphocytes.

  2025cites this paper
• B7–H3 and c-MET in advanced prostate cancer: exploring possibilities of novel bi-specific drug development

  2025cites this paper
• Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma.

  2025cites this paper
• High B7-H3 protein expression in Medulloblastoma is associated with metastasis and unfavorable patient outcomes

  2025cites this paper
• Molecular Imaging of B7-H3-Targeting Bispecific T Cell-Engaging Antibody MGD009 in Glioblastoma Models.

  2025cites this paper
• B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the Literature

  2025cites this paper
• Prognostic Significance of B7H3 Expression in Solid Tumors: A Systematic Review and Meta-Analysis

  2025cites this paper
• AN IMMUNOHISTOCHEMICAL AND MOLECULAR GENETIC STUDY OF 60 COLORECTAL CARCINOMA BRAIN METASTASES IN PURSUIT OF PREDICTIVE BIOMARKERS FOR CANCER THERAPY.

  2025cites this paper
• Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches

  2025cites this paper
• B7-H3 in the tumor microenvironment: Implications for CAR T cell therapy in pediatric solid tumors

  2025cites this paper
• B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer models

  2025cites this paper
• The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages

  2024cites this paper
• B7H3 Immune Checkpoint Overexpression Is Associated with Decreased Complete Response Rates to Neoadjuvant Therapy in Locally Advanced Rectal Cancer

  2024cites this paper
• Recent developments in immunotherapy for gastrointestinal tract cancers

  2024cites this paper
• B7-H3 Expression in Breast Cancer and Brain Metastasis

  2024cites this paper
• Survival and clinicopathological significance of B7-H3 in bladder cancer: a systematic review and meta-analysis

  2024cites this paper
• New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3

  2024influential citation
• Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy

  2023cites this paper
• Alternative immune checkpoints in immunoregulatory profile of cancer stem cells

  2023cites this paper
• A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC

  2023cites this paper
• B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention

  2023cites this paper
• B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy

  2023cites this paper
• Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3.

  2023cites this paper
• CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer

  2023cites this paper
• B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours

  2023cites this paper
• Exosomal B7-H3 facilitates colorectal cancer angiogenesis and metastasis through AKT1/mTOR/VEGFA pathway.

  2023cites this paper
• Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments

  2023cites this paper
• New frontiers in immune checkpoint B7-H3 (CD276) research and drug development

  2023cites this paper
• Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types

  2023cites this paper
• The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

  2022cites this paper
• The Role of NcRNAs to Regulate Immune Checkpoints in Cancer

  2022cites this paper
• A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity

  2022cites this paper
• B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma

  2022cites this paper
• Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3

  2022cites this paper
• To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3.

  2022cites this paper
• Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy

  2021cites this paper
• The role of B7-H3 in tumors and its potential in clinical application.

  2021cites this paper
• Immune Profiling of Medullary Thyroid Cancer—An Opportunity for Immunotherapy

  2021cites this paper
• B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors

  2021cites this paper
• miRNAs as novel immunoregulators in cancer.

  2021cites this paper
• CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1

  2021cites this paper
• A high-throughput magneto-electrochemical array for the integrated isolation and profiling of extracellular vesicles from plasma

  2021cites this paper
• Non-cytomembrane PD-L1: an atypical target for cancer.

  2021cites this paper
• B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer.

  2021cites this paper
• The Role of CD276 in Cancers

  2021cites this paper
• B7-H3 and digestive system cancers

  2021cites this paper
• A three-phase trans-ethnic study reveals B7-H3 expression is a significant and independent biomarker associated with colon cancer overall survival.

  2021cites this paper
• Identification of a ferroptosis-associated gene signature and the related therapeutic targets in head and neck squamous carcinoma.

  2021cites this paper
• What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy

  2021cites this paper
• What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)

  2021cites this paper
• Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer

  2021cites this paper
• B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma

  2020cites this paper
• Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas

  2020cites this paper
• B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression

  2020cites this paper
• Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy

  2020cites this paper
• Spatiotemporal Changes in Checkpoint Molecule Expression.

  2020cites this paper
• Combination Therapies with Anti-angiogenesis and B7-H3 Blockade in Cancers

  2020influential citation
• News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors.

  2020cites this paper
• B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival.

  2020cites this paper
• B7-H3 targeted antibody-based immunotherapy of malignant diseases

  2020influential citation
• B7-H3 immune checkpoint protein in human cancer.

  2019cites this paper
• Immune Checkpoints of the B7 Family. Part 2. Representatives of the B7 Family B7-H3, B7-H4, B7-H5, B7-H6, B7-H7, and ILDR2 and Their Receptors

  2019cites this paper
• B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors

  2019cites this paper
• An improved method to build lung cancer PDX models by surgical resection samples and its association with B7-H3 expression

  2019cites this paper
• High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation

  2019cites this paper
• B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2

  2019cites this paper
• B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models

  2019cites this paper
• Roles of B7-H3 in Cervical Cancer and Its Prognostic Value

  2018cites this paper
• High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.

  2018cites this paper
• Programmed death ligand‐1 expression as immunotherapeutic target in sinonasal cancer

  2018cites this paper
• Rôle de la protéine immuno-régulatrice PD-L1 sur le métabolisme des cellules tumorales

  2018cites this paper
• Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice

  2018cites this paper
• B7‑H3 promotes malignant progression of muscle‑invasive bladder cancer.

  2018influential citation
• Immunoregulatory Protein B7-H3 Regulates Cancer Stem Cell Enrichment and Drug Resistance through MVP-mediated MEK Activation

  2018cites this paper
• Genetic and clinical characterization of B7‐H3 (CD276) expression and epigenetic regulation in diffuse brain glioma

  2018cites this paper
• B7H3 As a Promoter of Metastasis and Promising Therapeutic Target

  2018cites this paper
• Immunohistochemistry predictive markers for primary colorectal cancer tumors: where are we and where are we going?

  2018influential citation
• The type 1 transmembrane glycoprotein B7‐H3 interacts with the glycolytic enzyme ENO1 to promote malignancy and glycolysis in HeLa cells

  2018cites this paper
• B7-H3 in Cancer - Beyond Immune Regulation.

  2018cites this paper
• Expression of CYP1B1 and B7-H3 significantly correlates with poor prognosis in colorectal cancer patients.

  2018cites this paper
• Generation of colorectal cancer cell line with mutation in B7H3 gene and its functional analysis

  2017cites this paper
• Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo

  2017cites this paper
• B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.

  2017cites this paper
• New checkpoints in cancer immunotherapy

  2017cites this paper
• Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis

  2017cites this paper
• New B7 Family Checkpoints in Human Cancers

  2017cites this paper
• B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells

  2017cites this paper
• The third group of the B7‐CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7‐H3

  2017cites this paper
• The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer

  2016cites this paper
• B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway

  2016cites this paper
• Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients

  2016cites this paper
• MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer

  2016cites this paper
• B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis

  2016cites this paper
• Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors

  2016cites this paper
• Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

  2016cites this paper